Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NT4

X-ray structure of SCoV2-PLpro in complex with small molecule inhibitor

Summary for 7NT4
Entry DOI10.2210/pdb7nt4/pdb
DescriptorNon-structural protein 3, PROFLAVIN, 1,2-ETHANEDIOL, ... (6 entities in total)
Functional Keywordsdrug repurposing, scov2-plpro inhibitor, hydrolase
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
Total number of polymer chains2
Total formula weight74162.75
Authors
Napolitano, V.,Mourao, A.,Bostock, M.,Matsuda, A.,Czarna, A.,Popowicz, G.M. (deposition date: 2021-03-09, release date: 2022-02-02, Last modification date: 2024-11-06)
Primary citationNapolitano, V.,Dabrowska, A.,Schorpp, K.,Mourao, A.,Barreto-Duran, E.,Benedyk, M.,Botwina, P.,Brandner, S.,Bostock, M.,Chykunova, Y.,Czarna, A.,Dubin, G.,Frohlich, T.,Holscher, M.,Jedrysik, M.,Matsuda, A.,Owczarek, K.,Pachota, M.,Plettenburg, O.,Potempa, J.,Rothenaigner, I.,Schlauderer, F.,Slysz, K.,Szczepanski, A.,Greve-Isdahl Mohn, K.,Blomberg, B.,Sattler, M.,Hadian, K.,Popowicz, G.M.,Pyrc, K.
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.
Cell Chem Biol, 29:774-, 2022
Cited by
PubMed Abstract: The COVID-19 pandemic caused by SARS-CoV-2 has been socially and economically devastating. Despite an unprecedented research effort and available vaccines, effective therapeutics are still missing to limit severe disease and mortality. Using high-throughput screening, we identify acriflavine (ACF) as a potent papain-like protease (PL) inhibitor. NMR titrations and a co-crystal structure confirm that acriflavine blocks the PL catalytic pocket in an unexpected binding mode. We show that the drug inhibits viral replication at nanomolar concentration in cellular models, in vivo in mice and ex vivo in human airway epithelia, with broad range activity against SARS-CoV-2 and other betacoronaviruses. Considering that acriflavine is an inexpensive drug approved in some countries, it may be immediately tested in clinical trials and play an important role during the current pandemic and future outbreaks.
PubMed: 35021060
DOI: 10.1016/j.chembiol.2021.11.006
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.68 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon